Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices
Top Cited Papers
- 19 December 2012
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 61 (3), 313-321
- https://doi.org/10.1016/j.jacc.2012.09.055
Abstract
No abstract availableKeywords
Funding Information
- HeartWare
- Thoratec
- Terumo and HeartWare
- Thoratec
This publication has 21 references indexed in Scilit:
- Risk Assessment for Continuous Flow Left Ventricular Assist Devices: Does the Destination Therapy Risk Score Work?Journal of the American College of Cardiology, 2012
- Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination TherapyCirculation: Heart Failure, 2012
- The Fourth INTERMACS Annual Report: 4,000 implants and countingThe Journal of Heart and Lung Transplantation, 2012
- Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart TransplantationJournal of the American College of Cardiology, 2011
- Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and MortalityCirculation, 2010
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DeviceJournal of the American College of Cardiology, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH EraCirculation, 2007
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Screening Scale Predicts Patients Successfully Receiving Long-term Implantable Left Ventricular Assist DevicesCirculation, 1995